Review
Version 1
Preserved in Portico This version is not peer-reviewed
MicroRNAs As Biomarkers of Brain Tumors
Version 1
: Received: 9 May 2024 / Approved: 13 May 2024 / Online: 13 May 2024 (06:51:58 CEST)
How to cite: Wojciech, J.; Mroczko, B. MicroRNAs As Biomarkers of Brain Tumors. Preprints 2024, 2024050788. https://doi.org/10.20944/preprints202405.0788.v1 Wojciech, J.; Mroczko, B. MicroRNAs As Biomarkers of Brain Tumors. Preprints 2024, 2024050788. https://doi.org/10.20944/preprints202405.0788.v1
Abstract
Brain tumors still remain a deadly cancer that, in most cases, is difficult to diagnose at an earlier stage. Therefore, it is necessary to develop rapid, sensitive methods for detecting cancer biomarkers. Such a biomarker may be a microRNA which expression level in body fluids is strongly correlated with cancer. Numerous studies have demonstrated changes in the expression of microRNAs in cerebrospinal fluid and blood samples collected from patients with brain tumors. These new biomarkers have the potential to help diagnose brain cancers at an early stage, avoiding the most invasive procedures. This review discusses the functional role of microRNAs and the prospects for their use as diagnostic biomarkers in patients with brain tumors.
Keywords
microRNAs; brain tumor
Subject
Medicine and Pharmacology, Oncology and Oncogenics
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment
